Listing 4.09 Heart Transplant in 2026: One Year Automatic Disability, Then Residual Impairment Under 4.02

By Anthony Albert, Benefits Research Director at Disability Exchange. Published July 9, 2026.

Heart transplant is the shortest listing in the entire Blue Book. The rule is one sentence long. It sounds simple. It is not.

What SSA gives you in Listing 4.09 is one year of automatic disability starting on the date of the transplant surgery. After that year, SSA is supposed to look at what is actually left in your body and rate the residual impairment against a different listing. That is where most transplant recipients get surprised. The first year is easy. Year two and beyond is where the medical review happens, and where a lot of people either stay on benefits or lose them.

This article walks through the exact wording of 4.09, how SSA counts the one year, how onset dates are set (which affects back pay), what happens at the first continuing disability review, and how the residual impairment gets scored under 4.02 chronic heart failure, 4.04 ischemic heart disease, or a non-cardiac listing if the transplant itself has caused new problems. Two real fact patterns show how it plays out.

The exact text of Listing 4.09

Here is the entire listing from SSA's Blue Book Section 4.00 Cardiovascular, Adult:

That is it. One sentence. No paragraphs. No sub-criteria. No MET tests, no ejection fraction cutoffs, no exercise stress rules. Just the transplant itself and the one year clock.

Compare that to Listing 4.02 chronic heart failure, which has three paths, MET testing, ejection fraction thresholds, and detailed medical documentation rules. 4.09 exists to spare transplant recipients from having to prove anything during the highest-risk period after surgery. SSA knows that rejection and infection risk peaks in the first 12 months. So the rule says do not make people fight for benefits during that year.

How the one year is counted

The one year starts on the date of the transplant surgery. Not the date you were listed on UNOS. Not the date of your diagnosis. Not the date you filed for SSDI. The clock starts on the surgical date shown in the operative report.

If your transplant happened on August 3, 2025, you are considered disabled through August 2, 2026 under 4.09 alone. On August 3, 2026, SSA will look at your residual impairment and either continue benefits, run a Continuing Disability Review (CDR), or transition your case to evaluation under a different listing.

The 12 months are calendar months. Not 12 months of continuous good health. Not 12 months of complications. Just 12 months from the surgical date.

Onset date does not equal the surgery date

This is where people get tripped up. The one year of automatic disability under 4.09 runs from the date of surgery. But your actual onset date for SSDI back pay purposes is usually earlier. SSA says so directly in Section 4.00H5b:

Translation: if you filed for SSDI before your transplant, or if you had severe heart failure that already met Listing 4.02 or another cardiac listing for 12 months before the surgery, your onset date is that earlier date. Not the surgery date. That matters for two reasons.

1. Back pay. SSDI back pay runs from your Established Onset Date (EOD) minus a 5-month waiting period. Earlier onset means more retroactive months of benefits.
2. Medicare timing. SSDI recipients qualify for Medicare 24 months after the first month of SSDI eligibility, which is 29 months from EOD. Earlier onset means Medicare kicks in sooner. That matters if you are burning through COBRA or private coverage.

See our companion article on Alleged Onset Date vs Established Onset Date for how SSA sets the EOD.

Being on the transplant waiting list is not automatic disability

Section 4.00H5c is explicit: SSA will not assume you became disabled when your name was placed on a transplant waiting list. Doctors put patients on the UNOS list as soon as they meet listing criteria for transplant candidacy, which is often well before their functional capacity has actually collapsed. Waiting list placement is a medical decision, not a disability determination.

So if you were listed on UNOS in March 2024, had transplant surgery in November 2025, and filed for SSDI in April 2024, SSA does not just default your onset to March 2024 because that is when you got listed. They will look at your objective medical evidence during that stretch. Ejection fraction, MET scores, hospitalizations, exercise capacity, functional status. If the evidence shows you met 4.02 or 4.04 in April 2024, your EOD gets set there. If your function was still preserved in April 2024 and did not collapse until later in the year, your EOD moves forward accordingly.

The one year ends. Then what?

Twelve months and one day after your surgery, Listing 4.09 stops paying the bills on its own. SSA now has to evaluate residual impairment under the appropriate listing. Section 4.00H5d spells out what that review looks at:

Three things get evaluated after the one year mark.

1. Cardiac function of the transplanted heart

Even a well-functioning graft can develop problems. Cardiac allograft vasculopathy (CAV) is coronary artery disease of the transplanted heart. It shows up in around 30 percent of heart transplant recipients by year 5 and 50 percent by year 10 per the International Society for Heart and Lung Transplantation registry. If CAV develops, SSA can evaluate it under Listing 4.04 ischemic heart disease.

Rejection episodes, arrhythmias post transplant, right ventricular dysfunction, and reduced exercise tolerance can all bring the case back under 4.02 chronic heart failure or 4.05 recurrent arrhythmias.

2. Side effects of immunosuppressive medication

Every heart transplant patient is on lifetime immunosuppression. Typical regimens include tacrolimus or cyclosporine (calcineurin inhibitors), mycophenolate mofetil, and prednisone. These drugs cause a long list of side effects that can independently meet listings.

• Kidney damage. Calcineurin inhibitors are nephrotoxic. Chronic kidney disease develops in about 25 to 30 percent of heart transplant recipients within 5 to 10 years. Evaluated under Listing 6.05.
• Post transplant diabetes. Steroid and tacrolimus induced diabetes hits roughly 20 percent of recipients. Evaluated under 9.00 endocrine.
• Bone disease. Steroid induced osteoporosis and avascular necrosis of hip or shoulder joints. Evaluated under 1.00 musculoskeletal.
• Post transplant lymphoproliferative disorder. A cancer-like complication driven by Epstein Barr virus reactivation under immunosuppression. Evaluated under 13.00 malignant neoplastic diseases.
• Chronic infection. Recurrent CMV, opportunistic bacterial or fungal infections. Can be evaluated under Listing 14.11 HIV framework or individual body system listings.

3. Functional capacity through an RFC

If your residual cardiac and medication issues do not meet a listing outright, SSA moves to a Residual Functional Capacity assessment. Exertional limits, environmental restrictions (avoiding sick contacts due to immunosuppression), and off-task time all get weighted. The RFC then interacts with the Medical Vocational Grid Rules.

The Continuing Disability Review after year one

SSA schedules CDRs based on medical improvement expectations. Heart transplant cases are almost always flagged Medical Improvement Expected (MIE), which triggers a review 6 to 18 months after the initial disability determination. For a transplant recipient, that often lines up with the end of the 4.09 one year window.

At the CDR, SSA uses the Medical Improvement Review Standard from 20 CFR 404.1594. Benefits continue unless SSA proves both of the following:

• Medical improvement has occurred related to your ability to work.
• You can now perform substantial gainful activity (SGA is $1,620 per month for non-blind in 2026).

That is the general rule. Read the full breakdown at Continuing Disability Review under 20 CFR 404.1594. A heart transplant CDR will typically pull cardiology follow up notes, echocardiogram results, endomyocardial biopsy findings, coronary angiography if CAV is suspected, blood work showing renal function and immunosuppressive drug levels, and any hospitalization records.

Worked example: Rebecca, 52, transplanted in Boston, MA

Worked example: Tomas, 47, transplanted in Houston, TX

How back pay is calculated for a transplant case

Back pay under SSDI has three moving parts.

1. Established Onset Date (EOD). The earliest date SSA agrees your impairment was disabling. For transplant patients, this is often before the surgery based on pre-transplant cardiac function.
2. Five month waiting period. No SSDI is paid for the first 5 full calendar months after the EOD.
3. Retroactive limit. SSDI back pay reaches back a maximum of 12 months before the SSDI filing date, even if the EOD is earlier.

Example: EOD is January 15, 2023. You filed February 2025. Waiting period is February through June 2023. First payable month is July 2023. But retroactive pay only goes back 12 months before filing, so back pay actually starts February 2024. You lose 7 months of otherwise payable back pay because you filed late. That is the cost of waiting.

See Date Last Insured for how insured status interacts with EOD.

Common mistakes with 4.09 claims

1. Filing after the transplant instead of before. This costs back pay every time.
2. Assuming the one year of automatic disability means one year of guaranteed benefits. The one year is a listing period. Actual SSDI payments still require insured status, the 5 month waiting period, and an EOD.
3. Not documenting side effects during year one. The one year of automatic disability is a good time to build a paper trail of everything the immunosuppression is doing to your body. That paper trail is what wins the CDR at 18 months.
4. Missing the follow up biopsy schedule. Endomyocardial biopsies at 1, 2, 3, 4, 6, 9, and 12 months post transplant are standard of care. Missing them makes your evidence file thinner and gives SSA less to work with at the CDR.
5. Not treating post transplant diabetes as a listing level impairment. Steroid induced diabetes with A1C above 7 and end organ complications can independently meet Listing 9.00 endocrine or drive an RFC restriction.

What to bring to the initial claim

• Cardiothoracic surgery operative report with the exact date of transplant.
• Pre-transplant cardiology records showing NYHA class, ejection fraction over time, MET testing or cardiopulmonary exercise testing (CPET), hospital admission records for decompensation.
• UNOS listing date and status changes.
• Any pre-transplant right heart catheterization data showing pulmonary artery pressures.
• Post-transplant follow up notes from your transplant cardiologist.
• Immunosuppression regimen and drug levels.
• Endomyocardial biopsy reports showing grade of any acute cellular or antibody mediated rejection.

What to bring to the first CDR

• Most recent echocardiogram with EF, wall motion, valve function.
• Most recent stress test or CPET with peak VO2.
• Coronary angiography or CT coronary angiogram if CAV screening has been done.
• Renal function labs showing creatinine and eGFR trend.
• Glycemic control (A1C) if diabetes has developed.
• Bone density scan if steroid osteoporosis is a concern.
• Documentation of any hospitalization for infection or rejection.
• Treating cardiologist RFC form addressing lifting, standing, walking, environmental restrictions, and off-task time.

Compassionate Allowance and heart transplant

Heart transplant is not on SSA's Compassionate Allowances (CAL) list because the listing itself is already a shortcut. Any adjudicator can approve a transplant case in minutes just by reading the operative report. The CAL program is designed to speed up cases that need pattern recognition or specialty knowledge. 4.09 does not need either. See our Compassionate Allowances 300 conditions guide for what qualifies.

How this interacts with 4.02 chronic heart failure

Most heart transplant claims meet Listing 4.02 chronic heart failure before surgery. So the EOD for back pay purposes usually sits on 4.02. Then 4.09 takes over for the 1 year window starting on the surgical date. Then at the CDR, SSA evaluates residual impairment against 4.02, 4.04, 4.05, or non-cardiac listings depending on what has happened to the recipient's body.

See our full walkthrough of Listing 4.02 Chronic Heart Failure in 2026 for how the ejection fraction and MET criteria work.

Frequently Asked Questions

Bottom line

Listing 4.09 is a legal shield for the first 12 months after heart transplant. It does not require any additional proof beyond the surgical report. What it does not do is guarantee benefits for life. The real work of a transplant SSDI case is building the paper trail during that first year so the CDR at 12 to 18 months finds continuing disability rather than medical improvement. Immunosuppression side effects, CAV screening, biopsy grades, and functional capacity documentation are what carry the case forward.

If you are pre-transplant, file now. If you are post transplant, start collecting the CDR file the day you leave the hospital.